1. Home
  2. SLI vs GERN Comparison

SLI vs GERN Comparison

Compare SLI & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard Lithium Ltd.

SLI

Standard Lithium Ltd.

HOLD

Current Price

$3.55

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.26

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLI
GERN
Founded
1998
1990
Country
Canada
United States
Employees
N/A
229
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SLI
GERN
Price
$3.55
$1.26
Analyst Decision
Strong Buy
Hold
Analyst Count
3
3
Target Price
$5.25
$2.17
AVG Volume (30 Days)
1.7M
14.8M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$26.91
Revenue Next Year
N/A
$43.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.49
$1.04
52 Week High
$6.40
$2.01

Technical Indicators

Market Signals
Indicator
SLI
GERN
Relative Strength Index (RSI) 41.76 33.21
Support Level $3.16 $1.24
Resistance Level $3.69 $1.29
Average True Range (ATR) 0.23 0.09
MACD -0.05 -0.02
Stochastic Oscillator 2.82 11.43

Price Performance

Historical Comparison
SLI
GERN

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company the company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: